Our Company

At Mileutis, we focus on discovery, development and commercialization of novel and biologically sourced,

safe and residue free therapies for animal health.

Mileutis developed a line of biopharmaceuticals that is revolutionizing

the way veterinarians treat a wide range of diseases. Mileutis’ first leading products are comprised of peptides and specific protein fragments that have a positive impact on body functions or conditions that influence health. Such peptides and specific proteins act through an immune-modulatory effect, therefore enabling the management of infectious and chronic diseases. Mileutis’ technology further reduced antibiotic use in animal health management.

Mileutis has been able to achieve such ambitious goals by investing in its core capabilities

which comprise mainly of its unique research team, and by building a unique R&D infrastructure located in the vicinity of the Weizmann Institute of Science in Rehovot. Our headquarters include manufacturing and state-of-the-art R&D facilities, cutting edge laboratories, clean rooms, utility rooms, storage facilities and management offices.

Mileutis Company Building
Investor Appeal - Motivation for Action